Banque Pictet & Cie’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-342,856
Closed -$34M 372
2019
Q3
$34M Sell
342,856
-20,203
-6% -$1.92M 0.65% 30
2019
Q2
$33.6M Sell
363,059
-44,220
-11% -$4.2M 0.62% 29
2019
Q1
$38.4M Sell
407,279
-251,934
-38% -$22M 0.74% 26
2018
Q4
$42.2M Sell
659,213
-100,814
-13% -$7.44M 0.86% 23
2018
Q3
$68M Buy
760,027
+15,445
+2% +$1.36M 1.26% 22
2018
Q2
$59.1M Buy
744,582
+20,120
+3% +$1.67M 1.16% 22
2018
Q1
$64.6M Sell
724,462
-36,044
-5% -$3.46M 1.36% 20
2017
Q4
$79.4M Buy
760,506
+78,026
+11% +$8.8M 1.59% 20
2017
Q3
$99.5M Buy
682,480
+28,243
+4% +$3.85M 2.25% 13
2017
Q2
$85M Sell
654,237
-12,400
-2% -$1.52M 2.02% 15
2017
Q1
$83M Sell
666,637
-56,249
-8% -$6.73M 2.05% 14
2016
Q4
$83.7M Buy
722,886
+37,604
+5% +$4.19M 2.15% 11
2016
Q3
$71.6M Buy
685,282
+5,385
+0.8% +$583K 1.85% 14
2016
Q2
$67.1M Buy
679,897
+455,930
+204% +$47.2M 1.79% 14
2016
Q1
$22.4M Buy
223,967
+208,242
+1,324% +$21.4M 0.58% 40
2015
Q4
$1.88M Buy
15,725
+3,215
+26% +$372K 0.05% 165
2015
Q3
$1.35M Buy
12,510
+9,710
+347% +$1.2M 0.04% 184
2015
Q2
$324K Sell
2,800
-5,235
-65% -$598K 0.03% 230
2015
Q1
$926K Sell
8,035
-1,100
-12% -$131K 0.02% 264
2014
Q4
$1.02M Buy
9,135
+4,615
+102% +$487K 0.03% 253
2014
Q3
$428K Hold
4,520
0.01% 312
2014
Q2
$388K Buy
+4,520
New +$344K 0.01% 308
2014
Q1
Sell
-8,520
Closed -$720K 454
2013
Q4
$720K Buy
+8,520
New +$674K 0.02% 235

Other funds holding CELG

Banque Pictet & Cie's CELG Position: Q4 2019 in Review

Banque Pictet & Cie sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 342,856 shares — an estimated $34M sold.

Banque Pictet & Cie first reported a position in CELG in Q4 2013 and held it in 23 quarters. The position peaked at $99.5M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Banque Pictet & Cie reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Banque Pictet & Cie sold 342,856 Celgene Corp shares in Q4 2019, an estimated $34M.
  • Banque Pictet & Cie first reported a position in Celgene Corp in Q4 2013 and held it in 23 quarters.
  • Banque Pictet & Cie's Celgene Corp position peaked at $99.5M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Banque Pictet & Cie's 13F filing for Q4 2019, filed 3 Feb 2020.